Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 12/20 | 0.53 |
| ▸ | CNR1 | P21554 | 12/20 | 0.53 |
| ▸ | DRD3 | P35462 | 1/20 | 0.52 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.52 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.52 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.52 |
| ▸ | GLRA1 | P23415 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11153015 | 0.78 | CNR2 (0.53) | CNR2CNR1DRD3 | |
| SCHEMBL10365544 | 0.77 | CNR1 (0.57) | CNR2CNR1NR1I2ADORA3SLC6A3 | |
| SCHEMBL10365155 | 0.76 | CNR2 (0.55) | CNR2CNR1NR1I2ADORA3SLC6A3 | |
| SCHEMBL24212283 | 0.75 | TP53 (0.38) | — | |
| SCHEMBL31545496 | 0.75 | TP53 (0.38) | — | |
| SCHEMBL11841958 | 0.75 | CNR2 (0.40) | CNR2CNR1DRD3NR1I2ADORA3 | |
| SCHEMBL10482673 | 0.73 | CNR2 (0.56) | CNR2CNR1DRD3GLRA1 | |
| SCHEMBL10372269 | 0.73 | CNR2 (0.56) | CNR2CNR1DRD3NR1I2ADORA3 | |
| SCHEMBL10365457 | 0.73 | CNR2 (0.58) | CNR2CNR1DRD3NR1I2ADORA3 | |
| SCHEMBL10482800 | 0.73 | CNR2 (0.56) | CNR2CNR1DRD3NR1I2ADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250090554-A1 | A METHOD OF TREATING DEPRESSION BY IMMUNE MODULATION | MYND LIFE SCIENCES INC (CA) | 2025-03-20 | — | — | US | disclosed |